Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Beta-Lactam Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Penicillin
1.2.3 Cephalosporins
1.2.4 Carbapenem
1.2.5 Monobacteria
1.3 Market by Application
1.3.1 Global Beta-Lactam Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Beta-Lactam Drugs Market Perspective (2018-2034)
2.2 Beta-Lactam Drugs Growth Trends by Region
2.2.1 Global Beta-Lactam Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Beta-Lactam Drugs Historic Market Size by Region (2018-2023)
2.2.3 Beta-Lactam Drugs Forecasted Market Size by Region (2024-2034)
2.3 Beta-Lactam Drugs Market Dynamics
2.3.1 Beta-Lactam Drugs Industry Trends
2.3.2 Beta-Lactam Drugs Market Drivers
2.3.3 Beta-Lactam Drugs Market Challenges
2.3.4 Beta-Lactam Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Beta-Lactam Drugs Players by Revenue
3.1.1 Global Top Beta-Lactam Drugs Players by Revenue (2018-2023)
3.1.2 Global Beta-Lactam Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Beta-Lactam Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Beta-Lactam Drugs Revenue
3.4 Global Beta-Lactam Drugs Market Concentration Ratio
3.4.1 Global Beta-Lactam Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Beta-Lactam Drugs Revenue in 2024
3.5 Beta-Lactam Drugs Key Players Head office and Area Served
3.6 Key Players Beta-Lactam Drugs Product Solution and Service
3.7 Date of Enter into Beta-Lactam Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Beta-Lactam Drugs Breakdown Data by Type
4.1 Global Beta-Lactam Drugs Historic Market Size by Type (2018-2023)
4.2 Global Beta-Lactam Drugs Forecasted Market Size by Type (2024-2034)
5 Beta-Lactam Drugs Breakdown Data by Application
5.1 Global Beta-Lactam Drugs Historic Market Size by Application (2018-2023)
5.2 Global Beta-Lactam Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Beta-Lactam Drugs Market Size (2018-2034)
6.2 North America Beta-Lactam Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Beta-Lactam Drugs Market Size by Country (2018-2023)
6.4 North America Beta-Lactam Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Beta-Lactam Drugs Market Size (2018-2034)
7.2 Europe Beta-Lactam Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Beta-Lactam Drugs Market Size by Country (2018-2023)
7.4 Europe Beta-Lactam Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Beta-Lactam Drugs Market Size (2018-2034)
8.2 Asia-Pacific Beta-Lactam Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Beta-Lactam Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Beta-Lactam Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Beta-Lactam Drugs Market Size (2018-2034)
9.2 Latin America Beta-Lactam Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Beta-Lactam Drugs Market Size by Country (2018-2023)
9.4 Latin America Beta-Lactam Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Beta-Lactam Drugs Market Size (2018-2034)
10.2 Middle East & Africa Beta-Lactam Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Beta-Lactam Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Beta-Lactam Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Detail
11.1.2 GlaxoSmithKline plc Business Overview
11.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Introduction
11.1.4 GlaxoSmithKline plc Revenue in Beta-Lactam Drugs Business (2018-2023)
11.1.5 GlaxoSmithKline plc Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Detail
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Beta-Lactam Drugs Introduction
11.2.4 Pfizer, Inc. Revenue in Beta-Lactam Drugs Business (2018-2023)
11.2.5 Pfizer, Inc. Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Detail
11.3.2 AstraZeneca plc Business Overview
11.3.3 AstraZeneca plc Beta-Lactam Drugs Introduction
11.3.4 AstraZeneca plc Revenue in Beta-Lactam Drugs Business (2018-2023)
11.3.5 AstraZeneca plc Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Detail
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Beta-Lactam Drugs Introduction
11.4.4 Merck & Co., Inc. Revenue in Beta-Lactam Drugs Business (2018-2023)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Beta-Lactam Drugs Introduction
11.5.4 Eli Lilly and Company Revenue in Beta-Lactam Drugs Business (2018-2023)
11.5.5 Eli Lilly and Company Recent Development
11.6 Shionogi & Co., Ltd.
11.6.1 Shionogi & Co., Ltd. Company Detail
11.6.2 Shionogi & Co., Ltd. Business Overview
11.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Introduction
11.6.4 Shionogi & Co., Ltd. Revenue in Beta-Lactam Drugs Business (2018-2023)
11.6.5 Shionogi & Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Beta-Lactam Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Penicillin
Table 3. Key Players of Cephalosporins
Table 4. Key Players of Carbapenem
Table 5. Key Players of Monobacteria
Table 6. Global Beta-Lactam Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Beta-Lactam Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Beta-Lactam Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Beta-Lactam Drugs Market Share by Region (2018-2023)
Table 10. Global Beta-Lactam Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Beta-Lactam Drugs Market Share by Region (2024-2034)
Table 12. Beta-Lactam Drugs Market Trends
Table 13. Beta-Lactam Drugs Market Drivers
Table 14. Beta-Lactam Drugs Market Challenges
Table 15. Beta-Lactam Drugs Market Restraints
Table 16. Global Beta-Lactam Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Beta-Lactam Drugs Market Share by Players (2018-2023)
Table 18. Global Top Beta-Lactam Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2024)
Table 19. Ranking of Global Top Beta-Lactam Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Beta-Lactam Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Beta-Lactam Drugs Product Solution and Service
Table 23. Date of Enter into Beta-Lactam Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Beta-Lactam Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Beta-Lactam Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Beta-Lactam Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Beta-Lactam Drugs Revenue Market Share by Type (2024-2034)
Table 29. Global Beta-Lactam Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Beta-Lactam Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Beta-Lactam Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Beta-Lactam Drugs Revenue Market Share by Application (2024-2034)
Table 33. North America Beta-Lactam Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Beta-Lactam Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Beta-Lactam Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Beta-Lactam Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Beta-Lactam Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Beta-Lactam Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Beta-Lactam Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Beta-Lactam Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Beta-Lactam Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Beta-Lactam Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Beta-Lactam Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Beta-Lactam Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Beta-Lactam Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Beta-Lactam Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Beta-Lactam Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 48. GlaxoSmithKline plc Company Detail
Table 49. GlaxoSmithKline plc Business Overview
Table 50. GlaxoSmithKline plc Beta-Lactam Drugs Product
Table 51. GlaxoSmithKline plc Revenue in Beta-Lactam Drugs Business (2018-2023) & (US$ Million)
Table 52. GlaxoSmithKline plc Recent Development
Table 53. Pfizer, Inc. Company Detail
Table 54. Pfizer, Inc. Business Overview
Table 55. Pfizer, Inc. Beta-Lactam Drugs Product
Table 56. Pfizer, Inc. Revenue in Beta-Lactam Drugs Business (2018-2023) & (US$ Million)
Table 57. Pfizer, Inc. Recent Development
Table 58. AstraZeneca plc Company Detail
Table 59. AstraZeneca plc Business Overview
Table 60. AstraZeneca plc Beta-Lactam Drugs Product
Table 61. AstraZeneca plc Revenue in Beta-Lactam Drugs Business (2018-2023) & (US$ Million)
Table 62. AstraZeneca plc Recent Development
Table 63. Merck & Co., Inc. Company Detail
Table 64. Merck & Co., Inc. Business Overview
Table 65. Merck & Co., Inc. Beta-Lactam Drugs Product
Table 66. Merck & Co., Inc. Revenue in Beta-Lactam Drugs Business (2018-2023) & (US$ Million)
Table 67. Merck & Co., Inc. Recent Development
Table 68. Eli Lilly and Company Company Detail
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Beta-Lactam Drugs Product
Table 71. Eli Lilly and Company Revenue in Beta-Lactam Drugs Business (2018-2023) & (US$ Million)
Table 72. Eli Lilly and Company Recent Development
Table 73. Shionogi & Co., Ltd. Company Detail
Table 74. Shionogi & Co., Ltd. Business Overview
Table 75. Shionogi & Co., Ltd. Beta-Lactam Drugs Product
Table 76. Shionogi & Co., Ltd. Revenue in Beta-Lactam Drugs Business (2018-2023) & (US$ Million)
Table 77. Shionogi & Co., Ltd. Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Beta-Lactam Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Beta-Lactam Drugs Market Share by Type: 2024 VS 2034
Figure 3. Penicillin Features
Figure 4. Cephalosporins Features
Figure 5. Carbapenem Features
Figure 6. Monobacteria Features
Figure 7. Global Beta-Lactam Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Beta-Lactam Drugs Market Share by Application: 2024 VS 2034
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Beta-Lactam Drugs Report Years Considered
Figure 13. Global Beta-Lactam Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Beta-Lactam Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Beta-Lactam Drugs Market Share by Region: 2024 VS 2034
Figure 16. Global Beta-Lactam Drugs Market Share by Players in 2024
Figure 17. Global Top Beta-Lactam Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Beta-Lactam Drugs Revenue in 2024
Figure 19. North America Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Beta-Lactam Drugs Market Share by Country (2018-2034)
Figure 21. United States Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Beta-Lactam Drugs Market Share by Country (2018-2034)
Figure 25. Germany Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Beta-Lactam Drugs Market Share by Region (2018-2034)
Figure 33. China Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Beta-Lactam Drugs Market Share by Country (2018-2034)
Figure 41. Mexico Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Beta-Lactam Drugs Market Share by Country (2018-2034)
Figure 45. Turkey Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Beta-Lactam Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. GlaxoSmithKline plc Revenue Growth Rate in Beta-Lactam Drugs Business (2018-2023)
Figure 48. Pfizer, Inc. Revenue Growth Rate in Beta-Lactam Drugs Business (2018-2023)
Figure 49. AstraZeneca plc Revenue Growth Rate in Beta-Lactam Drugs Business (2018-2023)
Figure 50. Merck & Co., Inc. Revenue Growth Rate in Beta-Lactam Drugs Business (2018-2023)
Figure 51. Eli Lilly and Company Revenue Growth Rate in Beta-Lactam Drugs Business (2018-2023)
Figure 52. Shionogi & Co., Ltd. Revenue Growth Rate in Beta-Lactam Drugs Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed